Literature DB >> 9701468

Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells.

T Chevalley1, R Rizzoli, D Manen, J Caverzasio, J P Bonjour.   

Abstract

Protein-energy malnutrition, which is common in elderly patients with osteoporotic hip fractures, is associated with reduced plasma levels of insulin-like growth factor-I (IGF-I). IGF-I is an important regulator of bone metabolism, particularly of osteoblastic bone formation both in vivo and in vitro. Pharmacological doses of arginine (Arg) increase growth hormone (GH) and IGF-I serum levels. Whether amino acids, particularly Arg, can directly modulate the production of IGF-I by osteoblasts is not known. We investigated the effects of increasing concentrations of Arg on IGF-I expression and production, alpha1(I) collagen expression and collagen synthesis, and cell proliferation and cell differentiation, as assessed by alkaline phosphatase (ALP) activity and osteocalcin (OC) release, in confluent mouse osteoblast-like MC3T3-E1 cells. The addition of Arg (7.5-7500 micromol/L, equivalent to 0.1- to 100-fold human plasma concentration) for 48 h increased IGF-I production (adjusted for cell number) in a concentration-dependent manner with a maximum of 2.3 +/- 0.3-fold at 7500 micromol/L Arg [x +/- standard error of the mean (SEM), n = 3 experiments, p < 0.01]. Arg (7.5-7500 micromol/L) increased the percentage of de novo collagen synthesis in a concentration-dependent manner (2.1 +/- 0.4-fold with 7500 micromol/L Arg, p < 0.001) and ALP activity with a maximal stimulation of 144% +/- 13% plateauing at 750 micromol/l Arg (p = 0.002). The steady state level of IGF-I messenger ribonucleic acid (mRNA) and alpha1(I) collagen mRNA (both normalized to cyclophilin mRNA) of cells incubated with Arg at high (100-fold) or low (0.1-fold) human plasma concentrations, was 1.4 +/- 0.2, 1.2 +/- 0.2, and 1.1 +/- 0.2 after 24 h for the 7.5, 1.8, and 0.9 kb IGF-I mRNA transcripts, respectively (n = 3 experiments) and 1.5 +/- 0.2 and 3.1 +/- 0.7 after 24 and 48 h, respectively, for the combined analysis of the 5.6 and 4.7 kb alpha1(I) collagen mRNA transcripts (n = 3 experiments). A maximal mitogenic effect (cell number) of +21% +/- 3% (p < 0.01) was obtained with 1000 micromol/L Arg. In contrast, Arg (7.5-7500 micromol/L) induced a reduction of OC production, which reached 30% +/- 3% with 7500 micromol/L Arg (p = 0.02). In conclusion, Arg stimulated IGF-I production and collagen synthesis in osteoblast-like cells. Thus, Arg may influence bone formation by enhancing local IGF-I production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701468     DOI: 10.1016/s8756-3282(98)00081-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  25 in total

1.  An accumulation of IGF-I and IGF-binding proteins in human umbilical cord.

Authors:  J Pałka; E Bańikowski; S Jaworski
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.

Authors:  J Wang; D Yan; A Zhao; X Hou; X Zheng; P Chen; Y Bao; W Jia; C Hu; Z-L Zhang; W Jia
Journal:  Osteoporos Int       Date:  2019-02-18       Impact factor: 4.507

3.  Does dietary protein reduce hip fracture risk in elders? The Framingham Osteoporosis Study.

Authors:  D Misra; S D Berry; K E Broe; R R McLean; L A Cupples; K L Tucker; D P Kiel; M T Hannan
Journal:  Osteoporos Int       Date:  2010-05-05       Impact factor: 4.507

Review 4.  [Malnutrition and osteoporosis].

Authors:  R Rizzoli; J P Bonjour
Journal:  Z Gerontol Geriatr       Date:  1999-07       Impact factor: 1.281

Review 5.  Energy Metabolism of the Osteoblast: Implications for Osteoporosis.

Authors:  Wen-Chih Lee; Anyonya R Guntur; Fanxin Long; Clifford J Rosen
Journal:  Endocr Rev       Date:  2017-06-01       Impact factor: 19.871

6.  Growth Hormone Deficiency and Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Maines Evelina; Morandi Grazia; Olivieri Francesca; Camilot Marta; Cavarzere Paolo; Gaudino Rossella; Antoniazzi Franco; Bordugo Andrea
Journal:  JIMD Rep       Date:  2015-01-23

7.  Nutritional approach for inhibiting bone resorption in institutionalized elderly women with vitamin D insufficiency and high prevalence of fracture.

Authors:  J-P Bonjour; V Benoit; O Pourchaire; B Rousseau; J-C Souberbielle
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

8.  Circulating amino acids are associated with bone mineral density decline and ten-year major osteoporotic fracture risk in older community-dwelling adults.

Authors:  Yi Su; Amany Elshorbagy; Cheryl Turner; Helga Refsum; Ruth Chan; Timothy Kwok
Journal:  Bone       Date:  2019-10-14       Impact factor: 4.398

Review 9.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

10.  Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats.

Authors:  Byoung-Seob Ko; Da Sol Kim; Suna Kang; Na Ra Lee; Jin Ah Ryuk; Sunmin Park
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.